bluebird bio Liabilities 2024

bluebird bio Aktienanalyse

What does bluebird bio do?

Bluebird bio Inc is a biotechnology company that was founded in 1992 in Cambridge, Massachusetts. The company specializes in the development of gene therapies and stem cell therapies for the treatment of cancer and genetic diseases. The goal of bluebird bio Inc is to develop innovative and effective therapies that can improve the lives of people with serious illnesses. bluebird bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing bluebird bio's Liabilities

bluebird bio's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating bluebird bio's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing bluebird bio's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

bluebird bio's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in bluebird bio’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about bluebird bio stock

What is the level of liabilities of bluebird bio this year?

bluebird bio has a debt balance of 358.6 M USD this year.

What were the liabilities of bluebird bio compared to the previous year?

The liabilities of bluebird bio have increased by 63.37% increased compared to the previous year.

What are the consequences of high debt for investors of bluebird bio?

High liabilities can pose a risk for investors of bluebird bio, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in bluebird bio?

Low liabilities mean that bluebird bio has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of bluebird bio affect the company?

An increase in liabilities of bluebird bio can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of bluebird bio affect the company?

A decrease in the liabilities of bluebird bio can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of bluebird bio?

Some factors that can influence the liabilities of bluebird bio include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of bluebird bio so important for investors?

The liabilities of bluebird bio are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can bluebird bio take to modify the liabilities?

To change its liabilities, bluebird bio can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does bluebird bio pay?

Over the past 12 months, bluebird bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, bluebird bio is expected to pay a dividend of 0 USD.

What is the dividend yield of bluebird bio?

The current dividend yield of bluebird bio is .

When does bluebird bio pay dividends?

bluebird bio pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of bluebird bio?

bluebird bio paid dividends every year for the past 0 years.

What is the dividend of bluebird bio?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is bluebird bio located?

bluebird bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von bluebird bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of bluebird bio from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did bluebird bio pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of bluebird bio in the year 2023?

In the year 2023, bluebird bio distributed 0 USD as dividends.

In which currency does bluebird bio pay out the dividend?

The dividends of bluebird bio are distributed in USD.